Diabetic Ulcers Treatment Market size is anticipated to reach USD 14 Billion by the end of 2033, growing at a CAGR of 6% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of diabetic ulcers treatment was USD 8 Billion. A growing number of people being diagnosed with diabetes worldwide is the primary factor for the market's growth. In 2019, diabetes caused 1.5 million deaths directly, with 48% of fatalities occurring before 70 years of age, according to the World Health Organization. The American Diabetes Association reported that nearly 37.3 million Americans, or 11.3% of the population, have diabetes. A total of 28.7 million of them are diagnosed, whilst 8.5 million remain undiagnosed. Diabetes is one of the common diseases that can affect people at a younger age. Moreover, increasing obesity issues, genetics, unhealthy diet habits, and urbanization are some of the reasons for the increase in diabetes risk.
The most common type of diabetic ulcer is a foot ulcer which is an open sore or wound and occurs in approximately 15 percent of diabetic patients. A foot ulcer is commonly found on the bottom of the foot. Six percent of those who develop a foot ulcer will require hospitalization for infection or other ulcer-related complications. The treatment for diabetic ulcers involves debriding the wound, treating any infection, revascularizing the area, and off-loading the area. Furthermore, growing awareness of treatment options for diabetic ulcers, improvements in treatment procedures, the approval of new products, and increasing research and development expenditure are projected to drive market growth over the forecast period. According to a recent report by the World Bank, global research and development expenditures are expected to be 2.63 percent of the country's total Gross Domestic Product (GDP) in 2020. The growth is considerably higher than 2.2% in 2018.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
6% |
|
Base Year Market Size (2022) |
USD 8 Billion |
|
Forecast Year Market Size (2033) |
USD 14 Billion |
|
Regional Scope |
|
Ulcer Type (Foot, Mouth, Other Ulcer)
The global diabetic ulcers treatment market is segmented and analyzed for demand and supply by ulcer type into foot ulcer, mouth ulcer, and others. Among these segments, the foot ulcer segment is anticipated to capture the largest market size owing to the rapidly growing number of people around the world who are experiencing diabetic foot ulcers (DFUs). A diabetic foot ulcer is a very serious condition in diabetic patients, as the immunity power and wound healing process are compromised in these people. The wound is even prone to get infectious over time if proper medications are not taken. For instance, every year, it is estimated that 9 to 26 million people around the world suffer from diabetic foot ulcers as a result of their diabetes. There is a significant chance that a diabetic foot ulcer will develop over the course of a patient's lifetime in 16 to 24% of patients with diabetes.
End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare)
The global diabetic ulcers treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and home care. Amongst these segments, the hospitals segment is expected to garner a significant share. The increasing number of hospitals across the world owing to the increasing number of patients suffering from various diseases, and the growing aging population is estimated to propel the growth of the market segment. The increasing favorable reimbursement policies from the government to support people with low income rises the demand for hospitals. The improvement in treatment methods and the presence of experienced doctors in the hospitals is expected to increase the market segment growth in the forecast period. As per the estimations, there are about 8,200 hospitals in Japan as of 2020 and 4,100 hospitals in Korea.
Our in-depth analysis of the diabetic ulcers treatment market includes the following segments:
|
By Ulcer Type |
|
|
By Treatment Type |
|
|
By End User |
|
North American Market Forecast
The North America diabetic ulcers treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the increasing spending on healthcare along with the presence of key market players in the region. The Centers for Medicare & Medicaid Services has reported that US healthcare spending in 2020 totaled USD 4.1 trillion, which represents 19.7% of the nation’s gross domestic product. Additionally, the increasing adoption of wound care products, coupled with the surging awareness regarding chronic wound care, the rise in technologically advanced research and development activities, and the huge diabetic population in the North America region are expected to fuel the diabetic ulcers treatment market growth in the region during the forecast period. The increasing urbanization and change in lifestyle, which include improper eating habits and a lack of exercise, are estimated to project market growth in the region as these factors increase the risk of diabetes. The rising number of the age-old population who have diabetes and foot ulcer issues are further predicted to boost the market’s growth in the region.
Orpyx Medical Technologies Inc., a company specializing in digital health therapeutics, has launched Orpyx SI Sensory Insoles incorporated with remote patient monitoring technology for the prevention of diabetic foot ulcers (DFUs) and ulcers associated with neuropathy.
As part of its therapeutic accessories portfolio, PENTAX Medical has launched a range of platforms dedicated to electrosurgical and argon plasma coagulation (APC) techniques - the ENDO ARC and ENDO PLUS.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?